Status:
RECRUITING
Efficacy of Video-Based Interactive Game Therapy in Interstitial Lung Patients
Lead Sponsor:
Istanbul University
Conditions:
Interstitial Lung Disease
Eligibility:
All Genders
40-65 years
Phase:
NA
Brief Summary
Interstitial lung disease (ILD) is a heterogeneous group of diseases consisting of variable amounts of inflammation and fibrosis and a wide variety of acute and chronic pulmonary disorders affecting b...
Detailed Description
Interstitial lung disease (ILD) is a heterogeneous group of diseases consisting of variable amounts of inflammation and fibrosis and a wide variety of acute and chronic pulmonary disorders affecting b...
Eligibility Criteria
Inclusion
- Diagnosed with ILD (Interstitial lung disease) by a chest diseases specialist, aged between 40-65 years, and have been under follow-up for at least 6 months according to the current ATS/ERS guidelines.
- Clinically stable, with no exacerbations or infections.
- Able to walk, with no visual or auditory impairments.
- Patients with cognitive abilities sufficient to understand commands.
Exclusion
- Orthopedic and neurological problems that could hinder exercise training.
- Changes in medical treatment during the study.
- Unstable cardiac diseases.
- Insufficient cooperation.
- Diagnosed visual, auditory, vestibular, or neurological problems that could affect balance.
Key Trial Info
Start Date :
January 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2025
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06087692
Start Date
January 1 2023
End Date
March 1 2025
Last Update
November 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
İstanbul Faculty of Medicine
Istanbul, Turkey (Türkiye), 34093